Author: Ken Dropiewski

GE Healthcare’s AIR Recon DL Technology Recognized by Popular Science Magazine in the ‘Best of What’s New’ Awards

AIR Recon DL is GE Healthcare’s pioneering deep-learning based technology that provides for clinical efficiency by enabling shorter scan times with higher resolution in MRI clinical procedures CHICAGO–(BUSINESS WIRE)–GE Healthcare announced today that it was recognized in the annual ‘Best of What’s New’ awards by Popular Science Magazine. The award highlights GE […]

Broadview Ventures Appoints Michael Mendelsohn, MD to its Strategic Advisory Board

BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced the appointment of Michael E. Mendelsohn, MD to its Strategic Advisory Board.  Dr. Mendelsohn is an internationally recognized cardiovascular physician-scientist, industry research leader and biopharma executive with four decades of broad healthcare and medical experience. Dr. Mendelsohn is […]

Soundbite Medical Solutions Announces Issuance of Two New U.S. Patent Further Expanding Coverage of its Shock Wave Technology

MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company leveraging its proprietary shock wave technology for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued two additional US patents. Patent No. 11,419,619, entitled “Method and system for […]

Medtronic’s Next-Gen Evolut™ FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting

London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration Medtronic’s newest generation self-expanding, transcatheter aortic valve replacement (TAVR) system, Evolut™ FX, significantly improved commissure alignment during TAVR procedures compared to earlier generation Evolut systems. A late breaker presentation at PCR […]

UAB Cardiogenomics Clinic and Allelica to perform polygenic risk score clinical implementation study

The Cardiogenomics Clinic at the University of Alabama at Birmingham and Allelica are partnering to perform a clinical implementation study to assess how polygenic risk score integration changes clinical management and health outcomes in a US health system. NEW YORK, Nov. 29, 2022 /PRNewswire/ — The UAB Cardiogenomics Clinic, led by Dr. Pankaj Arora, is […]

Neovasc Announces Progress on COSIRA-II Clinical Trial

VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical Trial (“Trial”) status. COSIRA-II is the U.S. Investigational Device Exemption (“IDE”) pivotal clinical trial the Company is executing for the Neovasc Reducer™ (“Reducer”) towards an approval […]

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

Insurer Positive Coverage Decisions Announced KIRKLAND, Wash.–(BUSINESS WIRE)–Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million insurance plan members across the U.S. The company reached this covered-lives milestone for the ASSURE WCD system less than one year from when the first […]

Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital

MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure. On September 12, 2022 privately […]

FEops’ AI-enabled Solution Changes TAVI Pre-procedural Decision in One Third of Patients, Associated With Favorable Clinical Outcomes

GENT, Belgium–(BUSINESS WIRE)–Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguideTM result in an important change of pre-procedural decision making of the heart team, associated with favorable clinical outcomes. This prospective multicenter […]